Xu Ya Jun

Dr. Xu is a co-founder of Epimab Biotherapeutics. Dr. Xu had held senior scientific positions at various global world-class pharmaceutical and healthcare companies including ChemPartner, Millennium Pharmaceutical and BASF/Abbott.

Dr. Xu holds Bachelor’s and Master’s degrees in Chemistry from the Beijing University of Chemical Technology, and a PhD in Biochemistry from Brandeis University. Dr. Xu had three years of Postdoctoral training at Harvard school of Public Health in department of Cell Biology, Endocrinology and Molecular Toxicology.